NEWBRY.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
NEWBRY.STNewbury Pharmaceuticals AB (publ)	$2.42	+3.42%	$63M	—
ACOU.STAcouSort AB	$2.66	-1.12%	$56M	—
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	$1.32	+6.00%	$3M	—
HEART.STScandinavian Real Heart AB (Publ)	$16.80	-1.18%	$143M	—
LPGO.STLipigon Pharmaceuticals AB (publ)	$0.00	-44.44%	$908901	—
ODI.STODI Pharma AB	$2.04	-1.92%	$37M	—
ONCOZ.STOncoZenge AB (publ)	$3.19	-0.93%	$45M	—

Source: Financial Modeling Prep · peers by sector/industry

Newbury Pharmaceuticals AB (publ)

Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.

www.newburypharma.com

Employees: 7
IPO / List date: Feb 4, 2022
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds NEWBRY.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in NEWBRY.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded NEWBRY.ST yet.